| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 15.05. | Outlook Therapeutics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 15.05. | Outlook Therapeutics, Inc.: Outlook Therapeutics Reports Financial Results for Second Quarter Fiscal Year 2024 and Provides Corporate Update | 187 | GlobeNewswire (Europe) | Positive opinion received from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for ONS-5010/LYTENAVA (bevacizumab gamma)United Kingdom (UK) Marketing Authorization... ► Artikel lesen | |
| 13.05. | Outlook Therapeutics, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 13.05. | Outlook Therapeutics, Inc.: Outlook Therapeutics Announces UK Submission of Marketing Authorization Application (MAA) for ONS-5010 as a Treatment for Wet AMD | 117 | GlobeNewswire (Europe) | UK submission for national MAA review follows recently received positive opinion from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) concerning the authorization... ► Artikel lesen | |
| 09.05. | Outlook Therapeutics, Inc.: Outlook Therapeutics® to Report Financial Results for Second Quarter Fiscal Year 2024 on May 16, 2024 and Host Inaugural Quarterly Conference Call and Webcast | 9 | GlobeNewswire (USA) | ||
| 02.05. | Outlook Therapeutics, Inc.: Outlook Therapeutics® to Present at the Retina World Congress 2024 | 8 | GlobeNewswire (USA) | ||
| 01.05. | Outlook Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 29.04. | Outlook Therapeutics, Inc.: Outlook Therapeutics® to Present at the Ophthalmology Innovation Summit (OIS) Retina Innovation Showcase | 12 | GlobeNewswire (USA) | ||
| 15.04. | Outlook Therapeutics, Inc.: Outlook Therapeutics® Announces Closing of Private Placement of $5.0 Million | 9 | GlobeNewswire (USA) | ||
| 12.04. | Outlook Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 02.04. | Outlook Therapeutics, Inc. - 8-K, Current Report | 5 | SEC Filings | ||
| 28.03. | Outlook Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 8 | SEC Filings | ||
| 26.03. | Outlook Therapeutics, Inc. - 8-K, Current Report | 9 | SEC Filings | ||
| 22.03. | Outlook Therapeutics, Inc.: Outlook Therapeutics Receives European Union Positive CHMP Opinion for ONS-5010 as a Treatment for Wet AMD | 158 | GlobeNewswire (Europe) | Positive opinion serves as a basis for final decision for potential authorization from the European Commission (EC), expected within 67 days ISELIN, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- Outlook... ► Artikel lesen | |
| 18.03. | Outlook Therapeutics, Inc. - 8-K, Current Report | 6 | SEC Filings | ||
| 18.03. | Outlook Therapeutics, Inc.: Outlook Therapeutics® Announces Closing of Private Placement of up to $159 Million | 5 | GlobeNewswire (USA) | ||
| 12.03. | Outlook Therapeutics, Inc.: Outlook Therapeutics Announces Effective Date for 1-for-20 Reverse Stock Split | 340 | GlobeNewswire (Europe) | ISELIN, N.J., March 12, 2024 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (the "Company"), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation... ► Artikel lesen | |
| 07.03. | Outlook Therapeutics, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 19.02. | Outlook Therapeutics Inc reports results for the quarter ended in December - Earnings Summary | 13 | Reuters | ||
| 14.02. | Outlook Therapeutics, Inc. - 10-Q, Quarterly Report | 3 | SEC Filings |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 2.723 |
| EVOTEC | 2.473 |
| NEL | 2.331 |
| TUI | 1.460 |
| GAMESTOP | 1.241 |
| BAYER | 1.151 |
| PLUG POWER | 1.146 |
| SUPER MICRO COMPUTER | 975 |
| BIONTECH | 968 |
| RHEINMETALL | 796 |
| VOLKSWAGEN | 725 |
| DEUTSCHE LUFTHANSA | 676 |
| BYD | 612 |
| JINKOSOLAR | 572 |
| DEUTSCHE BANK | 563 |
| TESLA | 557 |
| SIEMENS ENERGY | 542 |
| MERCEDES-BENZ | 523 |
| COMMERZBANK | 509 |
| THYSSENKRUPP | 504 |
| AIXTRON SE | 491 |
| BASF | 459 |
| RWE | 441 |
| RENK GROUP | 429 |
| INFINEON | 374 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
